Navigation Links
Lyme Disease-Pipeline Insights, 2014
Date:9/3/2014

LONDON, Sept. 3, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Lyme Disease-Pipeline Insights, 2014

http://www.reportlinker.com/p02278639/-Lyme-Disease-Pipeline-Insights-2014.html

SUMMARY
DelveInsight's," Lyme Disease-Pipeline Insights, 2014", report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Lyme Disease. This report provides information on the therapeutic development based on the Lyme Disease dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.

Scope
- The report provides a snapshot of the global therapeutic landscape of Lyme Disease
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Lyme Disease pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Lyme Disease and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Reasons to buy
- Complete Pipeline intelligence and complete understanding over therapeutics development for Lyme Disease
- Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
- Devise corrective measures for pipeline projects by understanding Lyme Disease pipeline depth and focus of Indication therapeutics
- Developing strategic initiatives to support your drug development activities.
- Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
- Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
- Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions
Table of Contents

- Lyme Disease Overview
- Lyme Disease Pipeline Therapeutics
- Lyme Disease Therapeutics under Development by Companies
- Lyme Disease Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Lyme Disease Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Lyme Disease Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Lyme Disease Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Lyme Disease – Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Lyme Disease – Discontinued Products
- Lyme Disease – Dormant Products
- Companies Involved in Therapeutics Development for Lyme Disease
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Lyme Disease, 2014
- Number of Products under Development by Companies
- Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
- Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
- Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
- Drug Candidates Profiles
- Lyme Disease Assessment by Monotherapy Products
- Lyme Disease Assessment by Combination Products
- Lyme Disease Assessment by Route of Administration
- Lyme Disease Assessment by Stage and Route of Administration
- Lyme Disease Assessment by Molecule Type
- Lyme Disease Assessment by Stage and Molecule Type
- Lyme Disease Therapeutics – Discontinued Products
- Lyme Disease Therapeutics – Dormant Products
- Products under Development by Companies, 2014

List of Figures

- Number of Products under Development for Lyme Disease, 2014
- Late Clinical Stage Products (Filed and Phase III), 2014
- Mid Clinical Stage Products (Phase II), 2014
- Early Clinical Stage Products (Phase I and IND Filed), 2014
- Discovery and Pre-Clinical Stage Products, 2014
- Lyme Disease Assessment by Monotherapy Products
- Lyme Disease Assessment by Combination Products
- Lyme Disease Assessment by Route of Administration
- Lyme Disease Assessment by Stage and Route of Administration
- Lyme Disease Assessment by Molecule Type
- Lyme Disease Assessment by Stage and Molecule Type

To order this report: Lyme Disease-Pipeline Insights, 2014
http://www.reportlinker.com/p02278639/-Lyme-Disease-Pipeline-Insights-2014.html

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001


'/>"/>
SOURCE Reportlinker
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Lung Disease-Pipeline Insights, 2014
2. Lymphedema-Pipeline Insights, 2014
3. Leg Ulcers-Pipeline Insights, 2014
4. Lipodystrophy-Pipeline Insights, 2014
5. Liposarcoma -Pipeline Insights, 2014
6. Liver Cirrhosis-Pipeline Insights, 2014
7. Liver Diseases-Pipeline Insights, 2014
8. Liver Fibrosis-Pipeline Insights, 2014
9. Liver Transplantation-Pipeline Insights, 2014
10. Lung Adenocarcinoma-Pipeline Insights, 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... 4, 2016  It,s time for an upgrade. There are many medical recorders on ... inch LCD, the illustrious DVMAXX HD  offers unparalleled connectivity and functionality.  Ampronix  is ... world class manufacturer of innovative technology.  Photo - http://photos.prnewswire.com/prnh/20160503/363416 ... ... ...
(Date:5/4/2016)... May 4, 2016 Valeritas Holdings, ... an alternative public offering (APO). This was accomplished via ... Valeritas, Inc. and a private placement of approximately 5 ... per share. Under the terms of the ... Valeritas Holdings, Inc. will trade on the OTC Markets ...
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Acute lymphocytic Leukemia ...  report to their offering.       ... Global Acute Lymphocytic Leukemia Market and Competitive ... Acute Lymphocytic Leukemia pipeline products, Acute Lymphocytic ...
Breaking Medicine Technology:
(Date:5/4/2016)... , ... May 04, 2016 , ... Natalie Jill ... with local company MitoXcell in preparation of the launch of her new book: Natalie ... plan is a nutritional guide designed to jump start a new healthy lifestyle featuring ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... all-LED multi-function small and compact tactical (6.7 inch) dual-light flashlights in models ... Vegas, model NSP-9842XL (average retail starting at $59.95) uses 2 included CR-123 batteries ...
(Date:5/4/2016)... Wisconsin (PRWEB) , ... May ... ... delivers next-level compression and support for knees, ankles, and elbows. Engineered with ... , Innovative 3D flat-bed manufacturing (opposed to ineffective circular knitting, common in ...
(Date:5/4/2016)... , ... May 04, 2016 , ... ... 2016, a powerful cellular therapy software application that helps blood and marrow ... patients. , Since Transtem’s initial launch, Mediware has continued to enhance core application ...
(Date:5/4/2016)... ... ... Over 40 athletic trainer’s (ATs) and athletic training students (ATSs) from across ... advocacy day. The annual lobbying effort is a collaboration between the Pennsylvania Athletic ... the day was to educate the elected legislators and the public about the profession ...
Breaking Medicine News(10 mins):